These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Tomatsu S; Orii KO; Vogler C; Nakayama J; Levy B; Grubb JH; Gutierrez MA; Shim S; Yamaguchi S; Nishioka T; Montano AM; Noguchi A; Orii T; Kondo N; Sly WS Hum Mol Genet; 2003 Dec; 12(24):3349-58. PubMed ID: 14583446 [TBL] [Abstract][Full Text] [Related]
6. A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months. Nakamura-Utsunomiya A; Nakamae T; Kagawa R; Karakawa S; Sakata S; Sakura F; Tani C; Matsubara Y; Ishino T; Tajima G; Okada S Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024277 [TBL] [Abstract][Full Text] [Related]
7. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161 [TBL] [Abstract][Full Text] [Related]
8. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations. Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177 [TBL] [Abstract][Full Text] [Related]
9. Mucopolysaccharidosis IVA: submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease. Fukuda S; Tomatsu S; Masuno M; Ogawa T; Yamagishi A; Rezvi GM; Sukegawa K; Shimozawa N; Suzuki Y; Kondo N; Imaizumi K; Kuroki Y; Okabe T; Orii T Hum Mutat; 1996; 7(2):123-34. PubMed ID: 8829629 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene. Terzioglu M; Tokatli A; Coskun T; Emre S Hum Mutat; 2002 Dec; 20(6):477-8. PubMed ID: 12442278 [TBL] [Abstract][Full Text] [Related]
12. Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease. Fateen EM; El Mawgoud HA; Eissa NR; Ibrahim MM; Aglan MS; Essawi ML Gene; 2017 Feb; 600():48-54. PubMed ID: 27825773 [TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice. Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938 [TBL] [Abstract][Full Text] [Related]
14. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects]. Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033 [TBL] [Abstract][Full Text] [Related]
15. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins. Tomatsu S; Vogler C; Montaño AM; Gutierrez M; Oikawa H; Dung VC; Orii T; Noguchi A; Sly WS Mol Genet Metab; 2007 Jul; 91(3):251-8. PubMed ID: 17498992 [TBL] [Abstract][Full Text] [Related]
16. Plasma Proteomic Analysis in Morquio A Disease. Álvarez JV; Bravo SB; Chantada-Vázquez MP; Barbosa-Gouveia S; Colón C; López-Suarez O; Tomatsu S; Otero-Espinar FJ; Couce ML Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200496 [TBL] [Abstract][Full Text] [Related]
17. Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA. Leal AF; Alméciga-Díaz CJ Gene Ther; 2023 Feb; 30(1-2):107-114. PubMed ID: 35581402 [TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Tomatsu S; Filocamo M; Orii KO; Sly WS; Gutierrez MA; Nishioka T; Serrato OP; Di Natale P; Montaño AM; Yamaguchi S; Kondo N; Orii T; Noguchi A Hum Mutat; 2004 Aug; 24(2):187-8. PubMed ID: 15241807 [TBL] [Abstract][Full Text] [Related]
19. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA). Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435 [TBL] [Abstract][Full Text] [Related]
20. Morquio A syndrome: cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene. Morris CP; Guo XH; Apostolou S; Hopwood JJ; Scott HS Genomics; 1994 Aug; 22(3):652-4. PubMed ID: 8001980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]